Search Results
12 items found for "prognosis"
- SSTR2 positively associates with EGFR and predicts poor prognosis in nasopharyngeal carcinoma
GPCR News < GPCRs in Oncology and Immunology SSTR2 positively associates with EGFR and predicts poor prognosis belongs to the receptor tyrosine kinases family and overexpression of EGFR has been linked to poor prognosis expression of SSTR2, high expression of EGFR, and high coexpression of SSTR2 and EGFR had a poorer prognosis expression of EGFR, high coexpression of EGFR and SSTR2, and EGFR/SSTR2 anyone high expression had a better prognosis Additionally, SSTR2 has potential as a new biomarker for poor prognosis in NPC patients."
- PAXIP1-AS1 is associated with immune infiltration and predicts poor prognosis in ovarian cancer
GPCRs in Oncology and Immunology PAXIP1-AS1 is associated with immune infiltration and predicts poor prognosis in OC cell lines, but the relationship between PAXIP1-AS1 expression and clinical characteristics, prognosis were used to evaluate the relationship between clinical characteristics and PAXIP1-AS1 expression, prognostic PAXIP1-AS1 could be a promising prognosis biomarker and response to immunotherapy for OC."
- Comparative Analysis of the GNAI Family Genes in Glioblastoma through Transcriptomics and Single-Cell Technologies
We investigated the prognostic values of the guanine nucleotide-binding protein G(i) alpha subunit (GNAI association in the tumor microenvironment between the gene expression of GNAI subunit 3 (GNAI3) and a poor prognosis Our findings suggest that the GNAI3 gene holds potential as a prognostic biomarker for GBM. Tags G-protein-coupled receptor (GPCR) , genome , glioblastoma , malignancy , molecular biomarker , prognosis
- Identification of S1PR4 as an immune modulator for favorable prognosis in HNSCC through machine learning
News < GPCRs in Oncology and Immunology Identification of S1PR4 as an immune modulator for favorable prognosis
- Activation of PI3K/Akt pathway by G protein-coupled receptor 37 promotes resistance to cisplatin-induced apoptosis in non-small cell lung cancer
tumors, particularly in non-small-cell lung cancer (NSCLC) METHODS: We explored the expression and prognosis We found that elevated GPR37 expression predicts an unfavorable prognosis. (2) It was demonstrated that
- Unbiased multitissue transcriptomic analysis reveals complex neuroendocrine regulatory networks mediated by spinal cord injury-induced immunodeficiency
Several studies have suggested that SCI-IDS is an independent risk factor for poor neurological prognosis immunosuppression in the periphery results in increased susceptibility to infection, leading to poor neurological prognosis
- A virally encoded GPCR drives glioblastoma through feed-forward activation of the SK1-S1P1 signaling axis
associated with accelerated progression of glioblastomas, aggressive brain tumors with a generally poor prognosis
- Simultaneous activation of CXC chemokine receptor 4 and histamine receptor H1 enhances calcium signaling and cancer cell migration
cancer cell lines and cancer tissues and that coexpression of CXCR4 and HRH1 is associated with poor prognosis
- Regulator of G protein signaling 16 restrains apoptosis in colorectal cancer through disrupting TRAF6-TAB2-TAK1-JNK/p38 MAPK signaling
899 CRC tissues revealed elevated RGS16 levels, correlating with clinicopathological features and CRC prognosis
- RGS20 promotes non-small cell lung carcinoma proliferation via autophagy activation and inhibition of the PKA-Hippo signaling pathway
Our study aimed to identify the role of RGS20 in NSCLC prognosis and delineate associated cellular and
- Molecular characterization of breast cancer cell pools with normal or reduced ability to respond to progesterone: a study based on RNA-seq
PR is an important prognostic factor in breast cancer.
- AGPCR 24 Student Flash Presentations
Before joining UAB as a graduate student, he worked in the EuGEF Research Group to identify novel prognostic